Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrice Rodien

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Trials|April 29, 2023
ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trialDana Hartl, Yann Godbert, Xavier Carrat, et al.
Trials|July 11, 2023
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trialDana Hartl, Yann Godbert, Xavier Carrat, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 2014
The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patientsSéverine Marcos, Julie Sarfati, Chrystel Leroy, et al.
Endocrine-Related Cancer|February 1, 2012
Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindredsMaria A Tichomirowa, Misu Lee, Anne Barlier, et al.
Endocrine-Related Cancer|September 22, 2016
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegalyIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.
European Journal of Endocrinology|November 9, 2020
ENSAT registry-based randomized clinical trials for adrenocortical carcinomaJoakim Crona, Eric Baudin, Massimo Terzolo, et al.
The Journal of Clinical Endocrinology and Metabolism|March 8, 2023
The Severity of Congenital Hypothyroidism With Gland-In-Situ Predicts Molecular Yield by Targeted Next-Generation SequencingLucie Levaillant, Natacha Bouhours-Nouet, Frédéric Illouz, et al.
Annales D'Endocrinologie|March 21, 2026
Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditionsLaurence Faivre, Camille Level, Régis Coutant, et al.
Annales D'Endocrinologie|May 8, 2026
Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditionsLaurence Faivre, Camille Level, Régis Coutant, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Trials|April 29, 2023
ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trialDana Hartl, Yann Godbert, Xavier Carrat, et al.
Trials|July 11, 2023
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trialDana Hartl, Yann Godbert, Xavier Carrat, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 2014
The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patientsSéverine Marcos, Julie Sarfati, Chrystel Leroy, et al.
Endocrine-Related Cancer|February 1, 2012
Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindredsMaria A Tichomirowa, Misu Lee, Anne Barlier, et al.
Endocrine-Related Cancer|September 22, 2016
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegalyIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.
European Journal of Endocrinology|November 9, 2020
ENSAT registry-based randomized clinical trials for adrenocortical carcinomaJoakim Crona, Eric Baudin, Massimo Terzolo, et al.
The Journal of Clinical Endocrinology and Metabolism|March 8, 2023
The Severity of Congenital Hypothyroidism With Gland-In-Situ Predicts Molecular Yield by Targeted Next-Generation SequencingLucie Levaillant, Natacha Bouhours-Nouet, Frédéric Illouz, et al.
Annales D'Endocrinologie|March 21, 2026
Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditionsLaurence Faivre, Camille Level, Régis Coutant, et al.
Annales D'Endocrinologie|May 8, 2026
Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditionsLaurence Faivre, Camille Level, Régis Coutant, et al.
Pageof 9